Evaluation of the in vitro and in vivo antihypertensive effect and antioxidant activity of blue corn hydrolysates derived from wet-milling//Evaluación del efecto antihipertensivo in vitro e in vivo y actividad antioxidante del hidrolizado de maíz azul derivado de la molienda húmeda by Montoya-Rodríguez, Alvaro et al.
155
Volumen XXII, Número 2
Revista de Ciencias Biológicas y de la Salud 
http://biotecnia.unison.mx
Universidad de Sonora
“El saber de mis hijos hará 
mi grandeza”
Evaluation of the in vitro and in vivo antihypertensive effect and 
antioxidant activity of blue corn hydrolysates derived from wet-milling 
Evaluación del efecto antihipertensivo in vitro e in vivo y actividad antioxidante del hidrolizado de maíz 
azul derivado de la molienda húmeda
Alvaro Montoya-Rodríguez, Evelyn Isabel Osuna-Gallardo, Francisco Cabrera-Chávez, Jorge Milán-Carrillo, 
Cuauhtémoc Reyes-Moreno, Evelia María Milán-Noris, Edith Oliva Cuevas-Rodríguez y Saraid Mora-Rochín*
Programa Regional del Noroeste para el Doctorado en Biotecnología y Maestría en Biotecnología de Alimentos, FCQB-UAS, 
Ciudad Universitaria, AP 1354, CP 80000, Culiacán, Sinaloa, México.
*Autor para correspondencia: Saraid Mora Rochín
Correo electrónico:  smora@uas.edu.mx
Recibido:  25 de octubre de 2019
Aceptado:  20 de diciembre de 2019
ABSTRACT
Hypertension is considered a risk factor for coronary 
heart disease, and its prevalence has increased substantially. 
Inhibition of angiotensin-converting enzyme (ACE-I) is key to 
lower blood pressure, making it an excellent treatment for 
hypertension. Corn (Zea mays L.) is an important source of 
bioactive peptides with potential anti-hypertensive activity 
related to ACE-I inhibition. These peptides can be obtained 
through the hydrolysis of corn gluten meal (CGM), as wet-
milling by-products. The aim was to evaluate the in vitro and 
in vivo ACE-I inhibitory activity of blue CGM hydrolysates. 
Enzymatic digestion in vitro of blue CGM was conducted at 
different times. Hydrolysis for 360 min significantly increased 
both soluble protein and antioxidant activity by 4 and 8-fold 
respectively, the maximum ACE-I inhibition (94.3 %) was 
observed with 260 min hydrolysate. Mice were treated with 
the blue CGM hydrolysate (260 min), captopril or PBS to test 
the bioavailability in vivo. The CGM hydrolysate was detected 
in serum after 5 and up to 30 min after ingestion, showing 
the maximum ACE-I inhibitory capacity (59 %) during the 
first 15 min. Overall, this work showed that the blue CGM 
hydrolysate could serve as a functional food ingredient with 
antihypertensive effect due to its blood pressure-lowering 
peptides. 
Keywords: blue corn, wet-milling, corn gluten meal, anti-
hypertensive, antioxidant activity
RESUMEN
La hipertensión es factor de riesgo en enfermedades 
coronarias, y su prevalencia ha aumentado sustancialmente. 
La inhibición de enzima convertidora de angiotensina (ECA) 
es clave para disminuir presión arterial, y excelente trata-
miento para hipertensión. El maíz (Zea mays L.) es fuente 
de péptidos bioactivos con actividad antihipertensiva por 
inhibición de ECA. Péptidos pueden obtenerse por hidrólisis 
de harina de gluten de maíz (HGM), como subproducto de 
molienda húmeda. El objetivo fue evaluar in vitro e in vivo 
actividad inhibitoria de ECA en hidrolizados de HGM azul. 
La digestión enzimática in vitro de HGM fue conducida a 
diferentes tiempos. La hidrólisis por 360 min aumento signifi-
cativamente proteína soluble y actividad antioxidante de 4 y 
8 veces, respectivamente; la máxima inhibición de ECA (94.3 
%) fue observada a 260 minutos del hidrolizado. Ratones 
fueron tratados con HGM hidrolizado (260 minutos), capto-
pril o PBS para evaluar biodisponibilidad in vivo. Después de 
la ingestión, HGM hidrolizado fue detectado en suero en 5 
hasta 30 minutos, mostrando máxima inhibición de ECA (59 
%) durante los primeros 15 minutos. En general, este trabajo 
mostró que hidrolizado de HGM podría servir como ingre-
diente funcional en alimentos con efecto antihipertensivo 
debido a péptidos reductores de presión arterial. 
Palabras clave: maíz azul, molienda húmeda, harina de glu-
ten de maíz, antihipertensivo, actividad antioxidante
INTRODUCTION
The increasing prevalence in hypertension and risk 
factors, such as coronary heart disease, stroke, and kidney 
disease, have recently received considerable attention. 
Nowadays, interest in using bioactive ingredients is the cor-
nerstone of hypertension prevention (Patten et al., 2016; Li 
et al., 2019; Zhu et al., 2019). Blood pressure regulation, con-
trolled by the renin-angiotensin-aldosterone system, is vital 
for preventing this disease. Angiotensin-converting enzyme 
(ACE) converts angiotensin I into the potent vasoconstrictor, 
angiotensin II, which elevates blood pressure by inducing 
vasoconstriction of the smooth muscle cells of the arteriole 
vasculature (Patten et al., 2016). Thus, ACE-I could be a target 
for inhibition to prevent hypertension in patients. 
Among all bioactive components found in foods, 
bioactive peptides have attracted the most attention due to 
their potential health benefits. These peptides are residues of 
2 to 20 amino acids (smaller than 10 kDa) and are frequently 
encrypted in food proteins from which they can be released 
through hydrolysis by digestive (pepsin and trypsin), micro-
bial, or plant (proteinases and peptidases) enzymes (Cian et 
al., 2015). Some reports suggest that different bioactive pep-
tides in diverse food proteins have the potential to inhibit the 
ACE-I (Cai et al., 2015; Zhu et al., 2019). Similarly, Li et al. (2019) 
reported that to date, 22 sequences of bioactive peptides 
have been identified from CGM, all of these could potentia-
lly be used in the treatment of hypertension and oxidative 
stress. Collectively, the search for compounds able to control/
prevent hypertension, such as protein-derived peptides from 
foods, represent a promising source for health-enhancing 
components (Patten et al., 2016; Li et al., 2019). 
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Corn (Zea mays L.) is a well-known grain, cultivated 
since ancient times and widely consumed around the world. 
Corn is used in different forms, the raw material for the ela-
boration of many products and the corn-derived products 
used for industrial applications (Da Silva-Messias et al., 2015). 
In Mexico exist at least 59 to 61 corn landraces. Among them, 
some pigmented landraces of colors such as yellow, black, 
red and blue, have been identified and approximately a third 
of the national producers harvest these corn varieties (Sán-
chez et al., 2000). In the state of Sinaloa, located in Northwest 
Mexico, the most important pigmented landrace is “Elotero 
de Sinaloa”, characterized by its blue color (Gaxiola-Cuevas et 
al., 2017). Uriarte-Aceves et al. (2015) worked with 15 Mexi-
can blue corn genotypes, and reported that they possess 
characteristics that make them appropriate for wet-milling 
processing. Traditionally, corn wet-milling is a process that 
separates the corn in high purity fractions called by-products, 
such as corn gluten meal (CGM), which contains the greatest 
percentage of protein (61 to 62%), consisting mainly of 65 % 
zeins and 30 % glutelins (Anderson and Lamsal, 2011; Zheng 
et al., 2015). Despite corn proteins are deficient in lysine, 
histidine, and tryptophan (essential amino acids), thus affec-
ting their nutritional quality, their overall amino acid profile, 
could make corn proteins a source of bioactive peptides (Zhu 
et al., 2019).
Some researchers have demonstrated the antioxidant 
properties (Li et al., 2008; Li et al., 2019) and anti-hypertensive 
benefits (Cai et al., 2015; Li et al., 2019) of white CGM. Thus, 
the blue CGM could also be a source of bioactive peptides 
with antioxidant and anti-hypertensive activities, due to its 
amino acid profile.
Blue corn consumption has been associated with 
health benefits, attributed to its high content of phenolic 
acids and anthocyanins (Gaxiola-Cuevas et al., 2017). Never-
theless, just a few reports have studied the antioxidant activi-
ty and anti-hypertensive properties of the CGM peptides that 
could be released from the hydrolyzed protein of blue corn. 
This study aimed to demonstrate the in vitro and in vivo ACE 
inhibitory activity of CGM hydrolysates from blue corn. 
MATERIALS AND METHODS
Corn sample
Blue creole corn (Zea mays L.) identified as “Elotero de 
Sinaloa” was collected from the municipality of Concordia, Si-
naloa, Mexico. The grains were grown and harvested during 
the 2016 season. Crops were handled following standard 
recommendations, and corn samples were hand cleaned to 
remove broken kernels and foreign material, placed in plastic 
bags, and stored at 4°C until wet-milling process.
Proximate composition
The AOAC (1990) official methods were used to de-
terminate the proximate composition of raw blue corn and 
blue CGM. Moisture was measured by drying the samples 
at 105 °C for 24 h (method 925.09B). For ash determination, 
the samples were incinerated at 550 °C (method 923.03). To 
evaluate crude fat, a Soxhlet apparatus with petroleum ether 
was used (method 920.39C), and for protein estimation, the 
micro-Kjeldahl method (N x 6.25) (method 960.52) was per-
formed. All experiments were conducted by triplicate.
Blue corn wet-milling process
The method by Singh et al. (1997) using 100 g of 
corn and slightly modified by Taboada-Gaytan et al. (2009) 
was used. The procedure consists of 6 steps: 1) soak stage, 
2) first milling, 3) germ recovery and coarse fiber, 4) second 
grinding, 5) fine fiber separation, and 6) separation of starch 
fraction and corn gluten meal (CGM). All fractions obtained 
were dried by the method 964.22 (AOAC, 1990). The yield 
percentage was calculated on a dry basis (db) for each frac-
tion.
Preparation of blue CGM hydrolysates
In vitro simulated digestion of blue CGM was per-
formed following the modified procedure by Montoya-Ro-
dríguez et al. (2014). Briefly, blue CGM flour was suspended 
in water (1:20 w/v) and a sequential enzyme digestion was 
carried out with pepsin (EC 3.4.23.1, 662 units/mg; enzyme/
substrate, 1:20 w/w; pH 2.0) and pancreatin (EC 232-468-9, 8 
x USP; enzyme/substrate, 1:20 w/w; pH 7.5). The solution was 
incubated at 37 °C at different times for each enzyme. The 
reaction was stopped by heating at 75 °C for 20 min, and the 
final hydrolysate was centrifuged at 20,000 × g for 15 min at 
4 °C. To determinate the hydrolysis, aliquots of 50 mL were 
initially hydrolyzed during 180 min with pepsin and after that 
with pancreatin for additional 20, 50, 80, and 180 min. The 
hydrolysates were then frozen, lyophilized, and kept at -20 °C 
until their use.
Measurement of soluble protein 
The total soluble protein of hydrolysates and blue 
CGM was determined by DCTM protein assay kit (Bio-Rad La-
boratories, Hercules, CA). The amount of soluble protein was 
calculated using a standard calibration curve built by using 
different bovine serum albumin concentrations from 125 to 
1250 µg/mL, in a PBS solution. The absorbance was measured 
in a spectrophotometer (GENESYS 20, Sigma Aldrich, USA) at 
690 nm.
Measurement of antioxidant activity
The antioxidant activity of blue CGM hydrolysates 
was evaluated with the oxygen radical absorbance capacity 
(ORAC) method, as previously described by Ou et al. (2009). 
The assay was performed using fluorescein as the fluorescent 
probe, AAPH as the radical generating agent, and Trolox as 
the standard. Hydrolysates, Trolox and AAPH were diluted 
with sodium phosphate buffer (75mM, pH 7.4). Hydrolysate 
aliquots (25 µL) were transferred into a 96-well plate, loaded 
into the plate holder of the Synergy Microplate Reader (Sy-
nergyTM HT Multi-Detection, BioTek, Inc., Winooski, VT) for 
the kinetic reading. Results of the protective effects of the 
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blue CGM hydrolysates and control were calculated based 
on the differences in the area under the sodium fluorescein 
decay curves (AUC) between the blank and the sample (Roy 
et al., 2010). The antioxidant activity of hydrolysates was ex-
pressed as µmol of Trolox equivalents (TE) per mg of soluble 
protein. 
SDS-PAGE of blue CGM hydrolysates
Samples of blue CGM were diluted with Laemmli 
Sample Buffer (Bio-Rad Laboratories, Hercules, CA) with 
β-mercaptoethanol and boiled for 5 min before loading. The 
protein profile of the hydrolysates was analyzed by SDS-PAGE 
using 10 and 12 % gels by the method of Laemmli (1970). 
A pre-stained precision Plus Protein Standard Dual color 
(Bio-Rad) was used. The gel was run at 110 V for 95 min in 
solution 10 % Tris-Glycine Buffer and 90 % water. Then, the 
gel was stained with Simplyblue TM Safe Staining solution 
(Thermo-Fisher Scientific, MA, USA) (Coomassie Brilliant Blue 
R250, distilled water, methanol, glacial acetic acid, trichlo-
roacetic acid) overnight. After that, it was washed-out with 
de-staining solution (distilled water, methanol, glacial acetic 
acid, trichloroacetic acid) once during 30 min. Finally, it was 
washed with distilled water.
Determination of percent inhibition of ACE-I activity
ACE inhibitory activity was carried out by the ACE 
Kit-WST assay kit (Lam et al., 2007). This assay is based in 
the action mechanism of the angiotensin-converting en-
zyme (ACE). This enzyme is a zinc-containing nonspecific 
dipeptidyl carboxypeptidase (EC 3.4.15.1), released mainly 
from endothelial cells of the capillaries of the lungs and 
kidneys, that converts angiotensin I to an active octapeptide 
vasoconstrictor, angiotensin II through the removal of two-
terminal amino acid residues (Lam et al., 2007). The assay de-
termines the amount of 3-hydroxybutyric acid produced and 
it is measured at 450 nm by spectrophotometric method. The 
inhibitory activity of the samples was calculated as follows 
and the results expressed as a percentage of ACE-I activity 
inhibition:
The inhibitory activity of ACE (% inhibition rate) = [(A 
Blank 1 - A sample) / (A Blank 1 - Blank 2)] X 100.
Evaluation of ACE-I inhibition in vivo 
The Bioethics Committee approved the study proto-
col of the Autonomous University of Sinaloa (CE-UACNYG-
2015-SEP-001). Female Balb/c mice (n=18, 11 weeks old, 
25-30 g) were purchased from BioInvert, México City, México. 
All mice were housed in plastic cages with stainless steel lids 
in a room with controlled temperature (28 °C) and lighting 
(12-h light/dark cycle). Food (Rodent Lab Chow 5001) and 
water were available ad libitum. To determine the in vivo 
bioavailability of blue CGM peptides as well as their efficacy 
inhibiting ACE-I activity, mice were divided randomly into 
one of three groups. The first group (n=6) received the 260 
min CGM hydrolysate (pepsin 180 + pancreatin 80 min) (2.5 
g/kg of body weight) resuspended in water. The second 
group (n=6) received the ACE inhibitor Captopril (25 mg/kg of 
body weight) solubilized in water (positive control). The third 
group (n=6) received only PBS (300 µL) (negative control). All 
treatments were administered by intragastric gavage using 
plastic feeding tubes (20 GA x 38 mm, Instech Laboratories, 
Inc). Blood samples were drawn from the tail vein before and 
after 5, 10, 15, 30, and 60 min of the intragastric interven-
tions. Blood samples were centrifuged at 2000 x g for 20 min 
at 24 °C to collect the serum (Ramírez-Torres et al., 2017). The 
presence of the antihypertensive compounds in the serum 
samples was determined using the ACE inhibition kit (ACE 
kit-WST-Dojindo Molecular Technologies, inc., Kumamoto, 
Japan) following the manufacturer´s instructions.
Statistical analysis 
All statistical analyses were analyzed using ANOVA 
procedures. Differences among treatments were determined 
using Tukey’s multiple comparison tests (p ≤ 0.05) using the 
statistical software Minitab v16. Values were expressed as 
means ± SD of three independent assays. 
RESULTS AND DISCUSSION
Chemical composition 
The chemical composition of raw blue corn and blue 
CGM varied significantly (p ≤ 0.05) (Table 1). The protein 
content in blue corn was 8.9 %. Our results are consistent to 
the protein values (7.6 to 11.2 %) reported in 15 blue corn 
genotypes from the state of Sinaloa (Uriarte-Aceves et al., 
2015), but slightly lower to the values (11.95 %) reported by 
Taboada-Gaytan et al. (2009). On the other hand, after wet-
milling, in the CGM we observed a 3.5-fold protein content 
increase (31.6% vs 8.9% in raw corn, p ≤ 0.05) compared to 
the raw material. During this process, the lactic acid used 
generates the hydrolysis of some corn molecules, mainly 
proteins (Uriarte-Aceves et al., 2015). The tabling method 
has been for years the most used technique for wet-milling, 
which separates the starch from the gluten meal fraction 
(Singh et al., 1997; Uriarte-Aceves et al., 2015).
The lipid content of the raw blue corn was 5.02 %. 
Uriarte-Aceves et al. (2015) reported lipid content values 
varying from 4.4 to 6.5 % in Mexican blue corn genotypes, 
while Taboada-Gaytan et al. (2009) have reported values 
slightly lower compared to this study. Compared to the raw 
material, a 2.72-fold increase (p ≤ 0.05) in the lipid content of 
CGM was observed (Table 1). 
Table 1. Chemical composition of blue corn and blue corn gluten meal 
Tabla 1. Composición química de maíz azul y harina de gluten de maíz azul
Properties RBC (%) CGM (%)
Proteins 8.9±0.2 b1 31.6±1.6 a
Lipids 5.0±0.5 b 13.6±0.4 a
Ashes 1.4±0.03 b 6.9±0.03a
Carbohydrates 84.6±0.3 a 47.9±1.6 b
1Mean ± SD (n= 3). Means with different superscripts in the same row are 
significantly different (Tukey test, p< 0.05). RBC= raw blue corn. CGM= blue 
corn gluten meal.
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It is known that CGM has 4.8-fold high ash content 
compared with raw corn. The higher concentration of ash in 
CGM (6.9 vs 1.4 % in raw corn, p ≤ 0.05) could be attributed to 
the solids solubilization, such as minerals, during the soaking 
step of the wet-milling process (Serna-Saldívar, 1996). Ove-
rall, our results suggest that the wet-milling procedure is a 
practical approach for the isolation of corn gluten meal from 
blue corn genotypes. 
Wet-milling characteristics
The blue corn products obtained during the wet-
milling process (starch, gluten, fiber, germ and soaking 
solids) were expressed as a percent of dry kernel weight. In 
industry, starch is considered an indicator of millability (i.e. 
milling characteristics). Starch yield and recovery are the 
most critical parameters to determine millability among corn 
genotypes (Singh et al., 1997; Uriarte-Aceves et al., 2015). 
In our study, the starch recovery obtained for blue 
corn was 48.7 % (Table 2). Although some authors have 
reported higher values of starch recovery (54.2 to 63.8 %) (Ta-
boada-Gaytan et al., 2010; Uriarte-Aceves et al., 2015), these 
variations could be attributed to the physical properties and 
chemical composition of the corn (Vignaux et al., 2006). The 
gluten recovery was 7.1 %, similarly to the results reported 
by Milasinovic et al. (2007) (5.3-13.5 %), and Uriarte-Aceves et 
al. (2015) (6.9-9.5 %). In contrast, Taboada-Gaytan et al. (2010) 
reported higher gluten recovery values (15.5-20.3 %). In spite 
of that, our results were higher than the typical gluten yields 
obtained at the industry level (5 %) (Johnson and May, 2003). 
The overall poor release of starch and gluten can be explai-
ned by the high protein content in the corn kernel (Vignaux 
et al., 2006).
The fiber content obtained was 25.5 %, comparable 
to the values reported by Uriarte-Aceves et al. (2015) (14.5-
25.7 %), and higher that the standard industrial fiber yield of 
11.5% as mentioned by Johnson and May (2003). The germ 
recovery during the wet-milling process of blue corn was 
3.8 %. Vignaoux et al. (2006) reported similar amounts of 
this fraction (4.6-7.0 %) using different scales of wet-milling 
procedures. However, the mean value found in this study is 
below than those published by the wet-milling industry (7.5 
%). 
Finally, the last by-product of the wet-milling process 
are the soaking solids. In the current study we found a mean 
of 2.9 %, this value was similar to the results reported by 
Uriarte-Aceves et al. (2015), although lower than those repor-
ted by Vignaoux et al. (2006) (7.6 %). These differences could 
be attributed to the use of different corn varieties.
Soluble protein
In Table 3 the solubility of blue corn gluten meal 
(CGM) proteins is shown. Initially, the soluble protein value 
for unhydrolyzed CGM was 3.9 mg/mL. However, the hydro-
lysates CGM sample had a significant (p ≤ 0.05) increase (up 
to 4-fold after pepsin and pancreatin hydrolysis) at different 
digestion times. These increments of protein solubility were 
observed after pepsin digestion of CGM at 180 min (11.2 
mg/mL), with highest value of protein solubility (15.1 mg/
mL) observed after 360 min digestion. These results could be 
related to the fact that the protein solubility increases with 
the hydrolysis, as it is primarily the result of the reduction in 
molecular weight and the increase in the number of polar 
groups. Our results are comparable with data reported by 
other researchers (Montoya-Rodríguez et al., 2014).
Antioxidant activity 
The hydrolysis process was essential to release com-
pounds with antioxidant activity compared with the unhy-
drolyzed form of CGM (Table 3). Some reports (Montoya-
Rodríguez et al., 2014), have explained that the antioxidant 
property increases (up to 8 times) as a function of the hydroly-
sis time (360 min) compared to the unhydrolyzed CGM (Table 
3). The high antioxidant activity (560.1 µmol TE/mg soluble 
Table 2. Blue corn wet-milling performance
Tabla 2. Rendimiento de molienda húmeda de maíz azul
Wet-milling fractions DB %
Starch 48.7 ± 2.01
Gluten 7.1 ± 0.3
Fiber 25.5 ± 1.0
Germ 3.8 ± 0.3
Soaking solids 2.9 ± 0.1
1Mean ± SD (n= 3). DB= Dry Basis
Table 3. Soluble protein and antioxidant activity of blue corn gluten meal












mg of soluble 
protein)
CGM 
(unhydrolyzed) 0 3.9 ± 0.2
c1 69.6 ± 2.2e
CGM + Pepsin 180 11.2 ± 1.5b 241.2 ± 8.1d
CGM + Pepsin 
180 min + 
Pancreatin
20 (200) 11.2 ± 1.2b 242.5 ± 4.3d
50 (230) 12.3 ± 0.4b 387.2 ±35.5b
80 (260) 13.1 ± 0.8ab 336.3 ± 9.50c
180 (360) 15.1 ± 0.4a 560.1 ± 23.4a
1Mean ± SD (n= 3). Means with different superscripts within columns are 
significantly different (Tukey test, p ≤ 0.05). CGM= blue corn gluten meal. TE 
= Trolox Equivalents.
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protein) of the hydrolysates could be explained, in part, to the 
structural changes of the corn proteins. Enzymatic hydrolysis 
promotes the unfolding and exposition of residues of active 
amino acids and availability to react with oxidants (Kong 
and Xiong, 2006). Cereals, like corn, have been reported to 
present a particular amino acid composition. They contain 
high amounts of hydrophobic amino acids such as leucine, 
alanine, and phenylalanine. Thus, CGM protein was thought 
to be an excellent source to obtain peptides with antioxidant 
activity (Li et al., 2008; Li et al., 2019). Also, low molecular 
weight peptides have often been associated with high anti-
oxidant activity (Cai et al., 2015). Li et al. (2008) reported that 
the antioxidant activity of corn peptides is closely connected 
with their molecular weight. They suggested that corn pep-
tides with a molecular weight between 0.5 to 1.5 kDa show 
higher antioxidant activity. Interestingly, Zhou et al. (2012) 
found variations in the antioxidant activity assessed by ORAC 
method between 0.066-0.19 µmol TE/ mg of dry weight in 
corn peptides of 1-10 kDa. Other authors report minor anti-
oxidant activity in blue corn from Chiapas and hybrid white 
corn using the same method (0.81 and 1.055 µM TE/mg of 
peptide) in hydrolyzed zein with peptides from 20-25 kDa 
(Díaz-Gómez et al., 2018). However, in the results obtained 
in our work we observed than the antioxidant activity found 
in hidrolyzed CGM is higher (241.2-560 µmol TE/mg soluble 
protein) than that reported by other authors (Zhou et al., 
2012; Díaz-Gómez et al., 2018). It is important to mention that 
the size of the protein or peptide fraction found in this study 
was between 19 to 31 kDa. However, fractions <10 kDa were 
also observed. Evidently, these results demonstrate impor-
tant differences regarding the starting material (CGM vs corn 
protein and zein fractions), and that hydrolysis conditions 
could have an important effect on the size and sequence of 
the active peptide (Díaz-Gómez et al., 2018). 
CGM protein profile
The SDS-PAGE analysis (Figure 1) was performed to 
assess the protein profile of the blue CGM hydrolysates. We 
noticed different protein profiles in the CGM, with proteins 
of different molecular weights ranging from 15 to 50 kDa. In 
Figure 1, it is shown that the protein profile changed during 
the hydrolysis time. Furthermore, at the end of hydrolysis, 
mainly lower molecular weight bands (peptides) are obser-
ved (< 10 kDa). Cai et al. (2015) described that corn peptides 
with a small molecular weight showed good anti-hyperten-
sive activity in both, in vitro and in vivo assays. In addition, 
a permanent band corresponding to α-Zein (27 kDa) was 
observed after hydrolysis (360 min). This band is related to 
the corn content of glutamine and proline, amino acids with 
poor solubility and relative low surface/weight ratio (Cabre-
ra-Chávez et al., 2012). Zheng et al. (2015) reported that the 
main protein fractions in CGM consist of approximately 65-68 
% (w/w) zeins and 22-33 % glutelins (w/w). These reports are 
in agreement with the results of this work.
Figure 1. SDS-PAGE of blue corn, blue CGM, and blue CGM hydrolysates 
at different times: A) Standard lane 1, lane 2-4 blue corn, lane 5-7 blue 
corn gluten meal; B) Standard lane 1, lane 2-4 blue CGM hydrolyzed with 
pepsin for 180 min, lane 5-7 blue CGM hydrolyzed with pepsin for 180 min 
+ pancreatin 20 min (200 min), lane 8-10 blue CGM hydrolyzed with pepsin 
for 180 min + pancreatin 50 min (230 min), lane 11-13 blue CGM hydrolyzed 
with pepsin for 180 min + pancreatin 80 min (260 min), lane 14-16 blue 
CGM hydrolyzed with pepsin for 180 min + pancreatin 180 min (360 min).
Figura 1. SDS-PAGE de maíz azul, HGM azul, e hidrolizados de HGM azul a 
diferentes tiempos: A) Línea estándar 1, línea 2-4 maíz azul, línea 5-7 harina 
de gluten de maíz azul ; B) Línea estándar 1, línea 2-4 HGM azul hidrolizado 
con pepsina por 180 minutos, línea 5-7 HGM azul hidrolizado con pepsina 
por 180 minutos + 20 minutos con pancreatina (200 minutos), línea 8-10 
HGM azul hidrolizado con pepsina por 180 minutos + 50 minutos con 
pancreatina (230 minutos), línea 11-13 HGM azul hidrolizado con pepsina 
por 180 minutos + 80 minutos con pancreatina (260 minutos), línea 14-16 
HGM azul hidrolizado con pepsina por 180 minutos + 180 minutos con 
pancreatina (360 minutos).
Inhibition of ACE-I activity
The results of angiotensin-converting enzyme (ACE) 
activity inhibition are presented as the percent of inhibition of 
the ACE obtained by the blue CGM after enzymatic digestion 
with pepsin for 180 min and after with pancreatin at different 
times (hydrolysates). Undigested (unhydrolyzed) CGM (time 
= 0) exhibited the highest (96.3 %) ACE-I inhibitory activity 
compared to all CGM-hydrolysates (89.7 to 92.9% inhibition) 
(Table 4). The 200 min hydrolysate (Pepsin 180 min + Pan-
creatin for 20 min) showed the highest percentage of ACE-I 
inhibition (94.5 %), while the lowest inhibition value (89.7 
%) was exhibited after 360 min digestion (Pepsin 180 min + 
Pancreatin 180 min). These results suggest that the digestion 
of blue CGM with pancreatin after 180 minutes of pepsin 
increases its ACE-I inhibitory activity, however digestion with 
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lysate was detected in the circulation after 5 min and its levels 
were maintained for up to 30 min post-supplementation. The 
bioavailability of the hydrolysate supplement was similar to 
that observed for the ACE-inhibitor drug captopril, whose 
levels were observed in serum at 5 min and maintained for 
up to 1h after administration. In the CGM hydrolysate group, 
the highest ACE-inhibitory activity was observed from 5 to 15 
min after ingestion (up to 59 % inhibition), and these values 
were significantly different (p ≤ 0.05) to the PBS group. The 
hydrolysate group decreased its inhibitory activity by ~44 % 
after 30 min and reached basal levels at 60 min (0 % inhibi-
tion) after treatment. 
The maximum ACE inhibitory activity in the captopril 
group started at 5 min and was maintained for up to 15 min 
after ingestion (up to 54.6 %, which was normalized to 100 % 
inhibition). Although the captopril showed a decrement of 
72 % in its activity after 60 min, it did not reach basal levels. 
In agreement with our data, early studies have re-
ported that in murine models, the maximum ACE percent 
inhibition of captopril in the blood is reached within the first 
20 min post-supplementation (Popovici et al., 2011; Ramirez-
Torres et al., 2017). Guo et al. (2019), demonstrated that the 
mixture of peptides derived from the CGM showed good 
long-term anti-hypertensive effect during 35 days in spon-
taneously hypertensive rats. The same authors also reported 
Table 4. ACE activity inhibition by blue CGM








CGM (unhydrolyzed) 0 96.3 ± 0.1a1
CGM+ Pepsin 180 92.9 ± 0.3c
CGM + pepsin 180 min 
+ pancreatin 20 (200) 94.5 ± 0.4
b
50 (230) 93.7 ± 0.6bc
80 (260) 94.3 ± 0.1b
180 (360) 89.7 ± 0.0d
1Mean ± SD (n= 3). Means with different superscripts within columns are 
significantly different (Tukey test, p ≤ 0.05). CGM= blue corn gluten meal. 
ACE = Angiotensin-converting enzyme.
pancreatin should not be longer than 80 minutes (i.e. 260 
min digestion), because after this time, the ACE-I inhibitory 
activity starts to decrease (Table 4). Thus the 260 min CGM 
hydrolysate will be use for the in vivo studies.
García et al. (2013) reported that the ACE inhibitor-
peptides could only exert their antihypertensive potential 
if they reach the cardiovascular system in their active form. 
After oral ingestion, they need to resist gastrointestinal di-
gestion by proteases and peptidases. Peptide degradation 
could occur during this process, with consequent inactiva-
tion. Unexpectedly, in this investigation we found that the 
unhydrolyzed CGM had higher ACE-I inhibitory activity than 
the hydrolyzed CGM at any time. It is essential to mention 
that several conditions contribute to the composition and 
functional activities of bioactive peptides. Such as enzyme 
specificity, degree of hydrolysis, enzyme/substrate ratio, 
hydrolysis time, and amino acid sequence (Zhu et al., 2019).
Determination of bioavailability
The bioavailability of the antihypertensive biopepti-
des was assessed in vivo in BALB/c mice. The CGM peptides 
capacity to reach circulation and had an effect on ACE-I 
activity was indirectly evaluated using the ACE-inhibition 
kit previously mentioned. Figure 2 shows the percentage of 
ACE-I activity inhibition at different time points after treating 
the mice with either blue CGM hydrolysate, captopril, or 
PBS solution. In this study, the PBS group showed an ACE-I 
inhibitory effect of 29 % at 5 min that started progressively 
decreasing after that until it reached basal levels after 15 min. 
Amir et al. (1980) explained that when mice suffer stress by 
an intragastric supplementation, enkephalins (considered a 
neuropeptide) are released, and these polypeptides could 
act as substrates for/or ACE-I inhibitors. The blue CGM hydro-
Figure 2. Bioavailability of blue CGM hydrolysate and ACE inhibitory 
capacity. Serum from mice supplemented with PBS solution (0.3 mL, n=6, 
negative control), blue CGM hydrolysates (260 min digestion) (2.5 g/kg, 
n=6), and captopril (25 mg/kg, n=6, positive control), were utilized for the 
assays. PBS (line blue), blue CGM hydrolysates (orange line), and captopril 
(gray line). Capital letters indicate differences across time points for each 
treatment (PBS, hydrolysate, and captopril). Lowercase letters indicate 
differences among treatments (PBS, hydrolysate, and captopril) at the same 
time point.
Figura 2. Biodisponibilidad de hidrolizados de HGM azul y capacidad inhi-
bitoria de ECA. Suero de ratones suplementados con HGM azul hidrolizada 
(260 minutos de digestión) (2.5 g/kg, n=6), y captopril (25 mg/kg, n=6, 
control positivo), fueron utilizados para el ensayo. PBS (línea azul), HGM 
azul hidrolizado (línea naranja), y captopril (línea gris). Letras mayúsculas 
indican diferencias entre tiempos para cada tratamiento (PBS, hidrolizado, 
y captopril). Letras minúsculas indican diferencias entre tratamientos (PBS, 
hidrolizado, y captopril) en el mismo tiempo.
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that high-dose of intragastrically administered CGM reduced 
the systolic blood pressure of rats from 18.2 to 28.6 mmHg 
(57 to 81 % reduction).
Collectively, our results suggest that CGM hydro-
lysates have the potential to inhibit ACE in vivo after the 
bioactive peptides reach the bloodstream. The positive 
effect was detected after 5 min of intragastric administration. 
Sánchez-Rivera et al. (2014), reported that the anti-hyperten-
sive peptides could be detected in blood after 5 min post-
intragastric-challenge and reach a maximum level after 30 
min of administration. In our study, serum from mice treated 
with the CGM hydrolysate obtained 30 min post-intragastric-
challenge was still able to inhibit 44 % of the ACE activity.
CONCLUSIONS
The wet-milling process generates high quality by-
products as gluten, starch, fiber, and germ present in blue 
corn. The obtained CGM showed high protein content and 
peptides released by simulated gastrointestinal digestion 
which showed high antioxidant activity. Furthermore, the 
CGM hydrolysate showed a maximum ACE-I inhibition of 59 
% and was bioavailable in mice from 5 to 30 min of adminis-
tration, similar to the pattern observed with captopril. 
Finally, our results suggest that consumption of blue 
CGM hydrolysates could serve as supplements or functional 
ingredients for the development of new foods, since they 
are a source of peptides with anti-hypertensive properties. 
Although, this research showed a positive effect of ACE-I 
inhibition with CGM hydrolysates, it is necessary to further 
determine the long-term effect of the hydrolysates in spon-
taneously hypertensive rats, monitoring their blood pressure 
after intragastric interventions at different time points.
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